Literature DB >> 29743721

Validation of the EUTOS long-term survival score in a recent independent cohort of "real world" CML patients.

Inge G P Geelen1, Fredrik Sandin2, Noortje Thielen3,4, Jeroen J W M Janssen4, Mels Hoogendoorn5, Otto Visser6, Jan J Cornelissen7, Martin Hoglund8, Peter E Westerweel9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29743721     DOI： 10.1038/s41375-018-0136-7

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Imatinib is still recommended for frontline therapy for CML.

Authors:  Andrew Hantel; Richard A Larson
Journal:  Blood Adv       Date:  2018-12-26

2.  Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.

Authors:  Michele Baccarani; Elisabetta Abruzzese; Vincenzo Accurso; Francesco Albano; Mario Annunziata; Sara Barulli; Germana Beltrami; Micaela Bergamaschi; Gianni Binotto; Monica Bocchia; Giovanni Caocci; Isabella Capodanno; Francesco Cavazzini; Michele Cedrone; Marco Cerrano; Monica Crugnola; Mariella D'Adda; Chiara Elena; Carmen Fava; Paola Fazi; Claudio Fozza; Sara Galimberti; Valentina Giai; Antonella Gozzini; Gabriele Gugliotta; Alessandra Iurlo; Gaetano La Barba; Luciano Levato; Alessandro Lucchesi; Luigia Luciano; Francesca Lunghi; Monia Lunghi; Michele Malagola; Roberto Marasca; Bruno Martino; Angela Melpignano; Maria Cristina Miggiano; Enrico Montefusco; Caterina Musolino; Fausto Palmieri; Patrizia Pregno; Davide Rapezzi; Giovanna Rege-Cambrin; Serena Rupoli; Marzia Salvucci; Rosaria Sancetta; Simona Sica; Raffaele Spadano; Fabio Stagno; Mario Tiribelli; Simona Tomassetti; Elena Trabacchi; Massimiliano Bonifacio; Massimo Breccia; Fausto Castagnetti; Fabrizio Pane; Domenico Russo; Giuseppe Saglio; Simona Soverini; Paolo Vigneri; Gianantonio Rosti
Journal:  Blood Adv       Date:  2019-12-23

Review 3.  New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia.

Authors:  Peter E Westerweel; Peter A W Te Boekhorst; Mark-David Levin; Jan J Cornelissen
Journal:  Front Oncol       Date:  2019-08-06       Impact factor: 6.244

4.  The EUTOS long-term survival score predicts disease-specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice-based cohort.

Authors:  Eriko Sato; Noriyoshi Iriyama; Michihide Tokuhira; Tomoiku Takaku; Maho Ishikawa; Tomonori Nakazato; Kei-Ji Sugimoto; Hiroyuki Fujita; Yuta Kimura; Isao Fujioka; Norio Asou; Norio Komatsu; Masahiro Kizaki; Yoshihiro Hatta; Tatsuya Kawaguchi
Journal:  Cancer Med       Date:  2020-10-10       Impact factor: 4.452

5.  Impact of BCR-ABL1 Transcript Type on Outcome in Chronic Myeloid Leukemia Patients Treated With Tyrosine Kinase Inhibitors: A Pairwise and Bayesian Network Meta-Analysis.

Authors:  Kangkang Chen; Yingying Ruan; Kewei Tian; Peisheng Xiong; Nan Xia; Jin Li; Wen Huang; Feiyan Cao; Qifeng Chen
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

6.  [Combination of socio-demographic and clinical co-variates for predicting treatment responses and outcomes in patients with chronic myeloid leukemia in the chronic phase].

Authors:  X S Zhang; Y Z Qin; Y Y Lai; H X Shi; X J Huang; Q Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2022-01-14

7.  Real-world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience.

Authors:  Josephine A Adattini; Annette S Gross; Nicole Wong Doo; Andrew J McLachlan
Journal:  Pharmacol Res Perspect       Date:  2022-10

Review 8.  European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia.

Authors:  A Hochhaus; M Baccarani; R T Silver; C Schiffer; J F Apperley; F Cervantes; R E Clark; J E Cortes; M W Deininger; F Guilhot; H Hjorth-Hansen; T P Hughes; J J W M Janssen; H M Kantarjian; D W Kim; R A Larson; J H Lipton; F X Mahon; J Mayer; F Nicolini; D Niederwieser; F Pane; J P Radich; D Rea; J Richter; G Rosti; P Rousselot; G Saglio; S Saußele; S Soverini; J L Steegmann; A Turkina; A Zaritskey; R Hehlmann
Journal:  Leukemia       Date:  2020-03-03       Impact factor: 11.528

9.  Validation of the EUTOS Long-Term Survival Score in Chinese Chronic Myeloid Leukemia Patients Treated with Imatinib: A Multicenter Real-World Study.

Authors:  Xiawan Yang; Yanliang Bai; Mingyue Shi; Wanjun Zhang; Junwei Niu; Chengye Wu; Lei Zhang; Zhiwei Xu; Xiang Liu; Yuqing Chen; Kai Sun
Journal:  Cancer Manag Res       Date:  2020-02-20       Impact factor: 3.989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.